e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database
Bruno Revol, Ingrid Jullian-Desayes, Sébastien Bailly, Michel Mallaret, Renaud Tamisier, Marie-Sara Agier, Frédéric Lador, Marie Joyeux-Faure, Jean-Louis Pépin
Source:
Eur Respir J, 51 (1) 1701855; 10.1183/13993003.01855-2017
Journal Issue:
January
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bruno Revol, Ingrid Jullian-Desayes, Sébastien Bailly, Michel Mallaret, Renaud Tamisier, Marie-Sara Agier, Frédéric Lador, Marie Joyeux-Faure, Jean-Louis Pépin. Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database. Eur Respir J, 51 (1) 1701855; 10.1183/13993003.01855-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Ticagrelor and central sleep apnea: analysis of VigiBase, the WHO pharmacovigilance database
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018
The method for diagnosis matters in sleep apnea. A systematic analysis of polygraphy and polysomnography data in the European Sleep Apnea Database (ESADA)
Source: Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer
Year: 2012
Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Clusters of sleep apnea phenotypes: A European perspective from the ESADA database
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019
Clinical description of sleep apnea syndrome in the elderly
Source: Annual Congress 2009 - Sleep apnoea across the ages
Year: 2009
Obstructive sleep apnoea hypopnoea syndrome (OSAHS) service - streamline of workflow by digital solutions
Source: Sleep and Breathing Conference 2021
Year: 2021
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories
Source: Eur Respir J 2011; 38: 635-642
Year: 2011
Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018
Telehealthcare interventions in the management of obstructive sleep apnoea hypopnoea syndrome (OSAHS) in continuous positive airway pressure (CPAP) users - A systematic review
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Resources and delays in the diagnosis of sleep apnea and hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 329s
Year: 2007
Validation study of a polygraph Watch pat in the diagnosis of sleep apnea-hypopnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 117s
Year: 2005
Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
Source: Eur Respir J, 55 (6) 2001323; 10.1183/13993003.01323-2020
Year: 2020
Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study
Source: Eur Respir J 2013; 41: 360-367
Year: 2013
Rates of CPAP therapy termination in different obstructive sleep apnoea patient phenotypes: analysis of the French nationwide health claims database
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Sleep apnoea and driving: how can this be dealt with?
Source: Eur Respir Rev 2007; 16: 189-195
Year: 2007
Efficiency of respiratory polygraphy in sleep apnoea and hypopnoea syndrome: a large multicentric study
Source: Annual Congress 2010 - Screening for sleep-disordered breathing
Year: 2010
Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy?
Source: Eur Respir J 2013; 41: 368-375
Year: 2013
Obstructive sleep apnea and cardiovascular risk markers in community individuals- Results from the sleep apnea and vascular evaluation (SAVE) study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Childhood sleep apnea syndrome (SAHS): experience in a sleep respiratory unit
Source: Annual Congress 2006 - Sleep apnoea in children
Year: 2006
A network-based approach to sleep apnea syndrome
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept